Amazonía Peruana
December 14, 2000
Miguel N. Alexiades
1 citation
El presente artículo describe dos elementos del chamanismo Ese Eja. El primero está asociado al eyámilukwa, identificado por los Ese Eja como el curandero tradicional. Un segundo complejo de prácticas chamánicas se basa en el empleo del alucinógeno vegetal ayahuasca. Introducido a comienzos de siglo, el ayahuasca está estrechamente asociado al contacto con mestizos y otras etnias amazónicas,...
Journal of Psychoactive Drugs
April 1, 1999
Jonathan Ott
136 citations
A summary is presented of human self-experiments or psychonautic bioassays of pharmahuasca--capsules containing crystalline N,N-dimethyltryptamine (DMT) plus harmine, as well as combinations of other psychoactive tryptamines with other beta-carbolines. The 1967 Holmstedt-Lindgren hypothesis of the ayahuasca effect--oral psychoactivity of DMT consequent to monoamine-oxidase (MAO) inhibition from...
Journal of Psychoactive Drugs
December 1, 1998
Ralph Metzner
140 citations
Western psychotherapy and indigenous shamanic healing systems have both used psychoactive drugs or plants for healing and obtaining knowledge (called "diagnosis" or "divination" respectively). While there are superficial similarities between psychedelic-assisted psychotherapy and shamanic healing with hallucinogenic plants, there are profound differences in the underlying worldview and...
Revista de Antropologia
December 30, 1995
Peter Gow
3 citations
This essay is a phenomenological ethnography or cinema as meaningful lived experience in the Alto Ucayali. It also explores the analogy between films and hallucinogen ayahuasca called "cinema of the forest" that renders the normally-invisihle powerful beings in visible form . If film and ayahuasca are similar, both experiences differ from dreaming.
Archives of Disease in Childhood
March 1, 1985
I A Auchterlonie, B. Benjamin
2 citations
1141 Objectives: The ayahuasca effect refers to the potentiation of action of hallucinogenic tryptamine alkaloids by co-administration of a plant extract containing MAO inhibitors, especially the beta-carboline harmine. The hallucinogenic tryptamines in the ayahuasca drink are primarily DMT and 5-MeO-DMT, the same tryptamines in extracts of Bufo skin, and the snuff yopo, another South American...
Medical Anthropology
1984
Marlene Dobkin De Rios
15 citations
This article examines the vidente, or seer phenomenon in the Peruvian Amazon city of Pucallpa, Peru, where fieldwork was conducted in 1977 and 1979. With the discovery of natural opiate-like substances in the body, called endorphins, researchers in the brain sciences were intrigued by man's ability to create his own opiate-like response to pain, ecstacy and stress. Paranormal phenomena, often...
Psychopathology
1978
Moises Lemlij
2 citations
Although it has been known for many years that hallucinogenic drugs are used by witch doctors in the Peruvian jungles for therapeutic purposes, there have been no descriptions of their use. We studied one type of treatment carried out in groups of about 10 to 12 ‘patients’, where the healer makes a magical diagnosis and provides a potion, usually ayahuasca (active hallucinogenic agent: harmine)...
Journal of AOAC International
1968
Robert J. Martin, Thomas G. Alexander
6 citations
Abstract Various ultraviolet, infrared, and TLC procedures are described for the separation and identification of hallucinogenic drugs. Specific methods for LSD, DMT, and psilocybin are also presented, along with general background information for the hallucinogenic drugs.
Verdad y Derecho. Revista Arbitrada de Ciencias Jurídicas y Sociales.
October 14, 2026
Meyerly Abigail Chasiluisa-Kajekai, María Emilia Luna-Velastegui
Los pueblos amazónicos de Pastaza conservan un saber extenso sobre plantas medicinales, pero hay pocos registros de cómo dosifican y combinan los preparados. El estudio documentó los criterios de dosificación y combinación de plantas medicinales para enfermedades comunes en comunidades shuar, kichwa y waorani. Se empleó un enfoque cualitativo, con revisión documental y entrevistas a siete...
Trials
October 14, 2026
Luca Pani, Fabio Tascedda
Abstract: Background: The registry record of psychedelic and related rapid-acting compounds is large, heterogeneous and laborious to synthesize by hand. We tested whether a large language model (LLM) with live access to the ClinicalTrials.gov application programming interface (API) could produce a timely, structured and reproducible characterization of this landscape. Methods: Cross-sectional...